Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
A study presented this week at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver compares [11C]choline-enhanced PET/CT and PET/MRI scanning in men with recurrent prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: PET/CT, PET/MRI, recurrent, restaging, scan | 10 Comments »
There were two posters presented at the Genitourinary Cancers Symposium regarding the use of “natural” agents in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: acai, mushroom, PSA, recurrent | 7 Comments »
The U.S. Food & Drug Administration (FDA), yesterday, approved an imaging agent known as Choline C11 Injection for “production and use” to detect recurrent prostate cancer in men receiving positron emission tomongraphy or PET scanning. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: C11, choline, PET, recurrent, scan | 20 Comments »
A research team at the University of Iowa is seeking patients to enroll in Phase II clinical trials of a new form of vaccine immunotherapeutic to treat men with recurrent prostate cancer. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: adenovirus, castration-resistant, recurrent, trial, vaccine | 8 Comments »
Malecare has just issued an updated version of its free book on recurrent and advanced prostate cancer. Many people have gained great benefit from the first edition of this book, and we are sure that the new version is equally useful. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Uncategorized | Tagged: advanced, book, Malecare, recurrent | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site